The correlation between NK cell and liver function in patients with primary hepatocellular carcinoma

Gut and Liver

Volumn 8, Issue 3, 2014, Pages 298-305

  Sha, Wei Hong ^a   Zeng, Xiao Hui ^b   Min, Lu ^c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Affiliated to Guangzhou University of Traditional Chinese Medicine   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Killer cells, natural; Liver neoplasms; Natural killer group 2D

Indexed keywords

NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADOPTIVE IMMUNOTHERAPY; ADULT; ARTICLE; BLOOD; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; NATURAL KILLER CELL; CASE CONTROL STUDY; CYTOTOXIC T LYMPHOCYTE; K562 CELL LINE; LIVER TUMOR; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LYMPHOCYTE SUBSETS; LYMPHOPENIA; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84901200106     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2014.8.3.298     Document Type: Article

References (8)

1. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002;20:853-885. (Pubitemid 34293442)
2. Coudert JD, Held W. The role of the NKG2D receptor for tumor immunity. Semin Cancer Biol 2006;16:333-343. (Pubitemid 44311504)
3. Pende D, Cantoni C, Rivera P, et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 2001;31:1076-1086.
4. Lu Z, Zhong N. The internal medicine. 7th ed. Beijing: People's Medical Publishing House, 2008.
5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227-242.
6. Conejo-Garcia JR, Benencia F, Courreges MC, et al. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biol Ther 2003;2:446-451.
7. Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-729.
8. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002;419:734-738. (Pubitemid 35177960)